Intralesional fluorouracil/epinephrine injectable gel for treatment of condylomata acuminata: A phase 3 clinical study

Archives of Dermatology

Volumn 133, Issue 1, 1997, Pages 67-73

  Swinehart, James M ^a   Sperling, Malcolm ^h   Phillips, Stephen ^b   Kraus, Stephen ^c   Gordon, Stephen ^d   McCarty, James M ⁱ   Webster, Guy F ^e   Skinner, Robert ^f   Korey, Andrew ^g   Orenberg, Elaine K ^g  

^a Colorado Medical Research Center ^*  (United States)

^b Future Healthcare Research Center   (United States)

^c Georgia Clinical Research Center Inc   (United States)

^d Crucible Group Inc   (United States)

^e THOMAS JEFFERSON UNIVERSITY   (United States)

^f UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^g Matrix Pharmaceutical Inc   (United States)

^h Private Practice   (United States)

ⁱ Private Practice   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONDYLOMA ACUMINATUM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FORMULATION; FEMALE; FOLLOW UP; HUMAN; INTRALESIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; REGIONAL PERFUSION;

EID: 0031046062     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.133.1.67     Document Type: Article

References (27)

1. Ferenczy A, Mitao M, Nagai N, Sitverstein SJ, Crum CP. Latent papillomavirus and recurring genital warts. N Engl J Med. 1985;313:784-788.
2. Ling MR. Therapy of genital human papillomavirus infections, I: indications for and justification of therapy. Int J Dermatol. 1992;31:682-686.
3. Dretler S, Klein L. The eradication of intraurethral condyloma acuminata with 5 percent 5-fluorouracil cream. J Urol. 1975;113:195-198.
4. von Krogh G. 5-Fluorouracil cream in the successful treatment of therapeutically refractory condylomata of the urinary meatus. Acta Derm Venereol (Stockh). 1976;56:297-301.
5. 2 laser for treatment of vaginal condylomata. Obstet Gynecol. 1984;64:773-778.
6. Krebs HB. The use of topical 5-fluorouracil in the treatment of genital condylomas. Obstet Gynecol Clin North Am. 1987;14:559-568.
7. Maymon R, Shulman A, Maymon BB, et al. Penile condylomata: a gynecological epidemic disease: a review of the current approach and management aspects. Obstet Gynecol Surv. 1994;49:790-800.
8. Krebs HB. Treatment of genital condylomata with topical 5-fluorouracil. Dermaiol Clin. 1991;9:333-341.
9. Miller E. The metabolism and pharmacology of 5-fluorouracil. J Surg Oncol. 1971;3:309-315.
10. Yu NY, Orenberg EK, Luck EE, Brown DM. Antitumor effect of intratumoral administration of fluorouracil/epinephrine injectable gel in C3H mice. Cancer Chemother Pharmacol. 1995;36:27-34.
11. Orenberg EK, Miller BH, Greenway HT, et al. The effect of intralesional 5-fluorouracil therapeutic implant (MPI 5003) for treatment of basal cell carcinoma. J Am Acad Dermatol. 1992;27:723-728.
12. Miller BH, Shavin JS, Cognetta A, et al. Nonsurgical treatment approach for basal cell carcinoma with intralesional fluorouracil/epinephrine injectable gel. J Am Acad Dermatol. 1997;36:72-77.
13. Lowe NJ, Orenberg EK, Nychay S, Korey A. Intradermal fluorouracil/ epinephrine injectable gel for treatment of psoriatic plaques. Arch Dermatol. 1995;131:1340-1341.
14. Swinehart J, Skinner R, McCarty J, et al. Intralesional chemotherapy with MPI 5003 for treatment of condylomata acuminata: muiticenter studies. Presented at the annual meeting of Clinical Dermatology 2000; May 18-23, 1993; Vienna, Austria.
15. DeLustro F, Fries J, Kang A, Katz S, Kaye R, Reichlin M. Immunity to injectable collagen and autoimmune disease: a summary of current understanding. J Dermatol Surg Oncol. 1988;14(suppl 1):57-65.
16. Swinehart J, Willson C, Lu S, Orenberg E, Korey A. Intralesional AccuSite (fluorouracil/epinephrine) injectable gel (MPI 5003) for treatment of condylomata acuminata. Presented at the annual meeting of the American Academy of Dermatology; July 30, 1994; San Francisco, Calif.
17. Krebs HB. Prophylactic topical 5-fluorouracil following treatment of human papillomavirus-associated lesions of the vulva and vagina. Obstet Gynecol. 1986; 64:837-841.
18. Sillman FH, Sedis A. Anogenital papillomavirus infection and neoplasia in immunodeficient women: an update. Dermatol Clin. 1991;9:353-369.
19. Gabriel G, Thin RNT. Treatment of anogenital warts: comparison of trichloracetic acid and podophyllin versus podophyllin alone. Br J Venereol Dis. 1983; 59:124-126.
20. Carpiniello VL, Malloy TR, Sedlacek TV, Zderic SA. Results of carbon dioxide laser therapy and topical 5-fluorouracil treatment for subclinical condyloma found by magnified penile surface scanning. J Urol. 1988;140:53-54.
21. Stone KM, Becker TM, Hadgu A, Kraus SJ. Treatment of external genital warts: a randomised clinical trial comparing podophyllin, cryotherapy, and electrodesiccation. Genitourin Med. 1990;66:16-19.
22. Carpiniello VL, Shoenberg M, Malloy TR. Long-term follow-up of subclinical human papillomavirus infection treated with the carbon dioxide laser and intraurethral 5-fluorouracil: a treatment protocol. J Urol. 1990;143:726-728.
23. Krieder J, Pickel M, Patrick S, Welsh P, Christensen N, Orenberg E. Intralesional chemotherapy with AccuSite (fluorouracil/epinephrine) injectable gel for treatment of human condylomata acuminata inhibits latent viral infection and induces regression of Shope papillomas. In: Program and abstracts of the 13th International Papillomairus Conference; October 11, 1994; Amsterdam, the Netherlands.
24. Yu N, Conley F, Luck EE, Brown DM. Response of mouse tumors to matrix-associated cisplatin intratumoral implants. Monogr Natl Cancer Inst. 1988;6:137-140.
25. Cooperman L, Michaeli D. The immunogenicity of injectable collagen, I: a 1 year prospective study. J Am Acad Dermatol. 1984;10:638-646.
26. Cooperman LS, Mackinnon V, Bechler G, Pharriss BB. Injectable collagen: a six year clinical investigation. Aesthetic Plast Surg. 1985;9:145-151.
27. Elson ML. The role of skin testing in the use of collagen injectable materials. J Dermatol Surg Oncol. 1989;15:301-303.